Logo image of HOMI.BR

HOME INVEST BELGIUM (HOMI.BR) Stock Fundamental Analysis

EBR:HOMI - Euronext Brussels - BE0974409410 - REIT - Currency: EUR

17.88  +0.1 (+0.56%)

Fundamental Rating

4

HOMI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 6 industry peers in the Residential REITs industry. While HOMI has a great profitability rating, there are quite some concerns on its financial health. HOMI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year HOMI was profitable.
HOMI had a positive operating cash flow in the past year.
HOMI had positive earnings in 4 of the past 5 years.
In the past 5 years HOMI always reported a positive cash flow from operatings.
HOMI.BR Yearly Net Income VS EBIT VS OCF VS FCFHOMI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

1.2 Ratios

HOMI's Return On Assets of 7.14% is amongst the best of the industry. HOMI outperforms 100.00% of its industry peers.
With an excellent Return On Equity value of 13.37%, HOMI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With a Return On Invested Capital value of 2.34%, HOMI is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
HOMI had an Average Return On Invested Capital over the past 3 years of 2.28%. This is in line with the industry average of 3.94%.
The 3 year average ROIC (2.28%) for HOMI is below the current ROIC(2.34%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.14%
ROE 13.37%
ROIC 2.34%
ROA(3y)3.97%
ROA(5y)4.7%
ROE(3y)8.26%
ROE(5y)9.76%
ROIC(3y)2.28%
ROIC(5y)2.2%
HOMI.BR Yearly ROA, ROE, ROICHOMI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20 25

1.3 Margins

The Profit Margin of HOMI (174.79%) is better than 100.00% of its industry peers.
The Operating Margin of HOMI (74.75%) is better than 66.67% of its industry peers.
HOMI's Operating Margin has improved in the last couple of years.
HOMI's Gross Margin of 92.09% is amongst the best of the industry. HOMI outperforms 83.33% of its industry peers.
HOMI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 74.75%
PM (TTM) 174.79%
GM 92.09%
OM growth 3Y2.87%
OM growth 5Y2.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.26%
GM growth 5Y0.84%
HOMI.BR Yearly Profit, Operating, Gross MarginsHOMI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HOMI is destroying value.
The number of shares outstanding for HOMI has been increased compared to 1 year ago.
Compared to 5 years ago, HOMI has more shares outstanding
The debt/assets ratio for HOMI has been reduced compared to a year ago.
HOMI.BR Yearly Shares OutstandingHOMI.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
HOMI.BR Yearly Total Debt VS Total AssetsHOMI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.79, we must say that HOMI is in the distress zone and has some risk of bankruptcy.
HOMI has a better Altman-Z score (0.79) than 66.67% of its industry peers.
The Debt to FCF ratio of HOMI is 41.18, which is on the high side as it means it would take HOMI, 41.18 years of fcf income to pay off all of its debts.
HOMI has a Debt to FCF ratio (41.18) which is in line with its industry peers.
HOMI has a Debt/Equity ratio of 0.82. This is a neutral value indicating HOMI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.82, HOMI is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 41.18
Altman-Z 0.79
ROIC/WACC0.39
WACC6.07%
HOMI.BR Yearly LT Debt VS Equity VS FCFHOMI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.40 indicates that HOMI may have some problems paying its short term obligations.
HOMI has a Current ratio of 0.40. This is comparable to the rest of the industry: HOMI outperforms 50.00% of its industry peers.
HOMI has a Quick Ratio of 0.40. This is a bad value and indicates that HOMI is not financially healthy enough and could expect problems in meeting its short term obligations.
HOMI's Quick ratio of 0.40 is in line compared to the rest of the industry. HOMI outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
HOMI.BR Yearly Current Assets VS Current LiabilitesHOMI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 293.46% over the past year.
Looking at the last year, HOMI shows a small growth in Revenue. The Revenue has grown by 7.21% in the last year.
The Revenue has been growing slightly by 7.46% on average over the past years.
EPS 1Y (TTM)293.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%555.14%
Revenue 1Y (TTM)7.21%
Revenue growth 3Y9.41%
Revenue growth 5Y7.46%
Sales Q2Q%5.94%

3.2 Future

HOMI is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.21% yearly.
Based on estimates for the next years, HOMI will show a small growth in Revenue. The Revenue will grow by 4.44% on average per year.
EPS Next Y-33.62%
EPS Next 2Y-17.65%
EPS Next 3Y-11.16%
EPS Next 5Y-8.21%
Revenue Next Year4.17%
Revenue Next 2Y4.84%
Revenue Next 3Y4.53%
Revenue Next 5Y4.44%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HOMI.BR Yearly Revenue VS EstimatesHOMI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
HOMI.BR Yearly EPS VS EstimatesHOMI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.62 indicates a rather cheap valuation of HOMI.
100.00% of the companies in the same industry are more expensive than HOMI, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 29.07. HOMI is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 14.86, which indicates a correct valuation of HOMI.
HOMI's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of HOMI to the average of the S&P500 Index (22.05), we can say HOMI is valued slightly cheaper.
Industry RankSector Rank
PE 5.62
Fwd PE 14.86
HOMI.BR Price Earnings VS Forward Price EarningsHOMI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HOMI is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HOMI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 37.8
EV/EBITDA 27.8
HOMI.BR Per share dataHOMI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

HOMI has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as HOMI's earnings are expected to decrease with -11.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.65%
EPS Next 3Y-11.16%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HOMI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HOME INVEST BELGIUM

EBR:HOMI (3/25/2025, 7:00:00 PM)

17.88

+0.1 (+0.56%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)05-21 2025-05-21
Inst Owners2.96%
Inst Owner ChangeN/A
Ins Owners3.11%
Ins Owner ChangeN/A
Market Cap361.18M
Analysts45.45
Price Target19.55 (9.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.14
Dividend Growth(5Y)-30.71%
DP18.34%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE 5.62
Fwd PE 14.86
P/S 10.09
P/FCF 37.8
P/OCF 13.85
P/B 0.77
P/tB 0.77
EV/EBITDA 27.8
EPS(TTM)3.18
EY17.79%
EPS(NY)1.2
Fwd EY6.73%
FCF(TTM)0.47
FCFY2.65%
OCF(TTM)1.29
OCFY7.22%
SpS1.77
BVpS23.18
TBVpS23.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.14%
ROE 13.37%
ROCE 3.13%
ROIC 2.34%
ROICexc 2.36%
ROICexgc 2.36%
OM 74.75%
PM (TTM) 174.79%
GM 92.09%
FCFM 26.68%
ROA(3y)3.97%
ROA(5y)4.7%
ROE(3y)8.26%
ROE(5y)9.76%
ROIC(3y)2.28%
ROIC(5y)2.2%
ROICexc(3y)2.3%
ROICexc(5y)2.22%
ROICexgc(3y)2.3%
ROICexgc(5y)2.22%
ROCE(3y)3.04%
ROCE(5y)2.94%
ROICexcg growth 3Y5.3%
ROICexcg growth 5Y3.29%
ROICexc growth 3Y5.28%
ROICexc growth 5Y3.3%
OM growth 3Y2.87%
OM growth 5Y2.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.26%
GM growth 5Y0.84%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 41.18
Debt/EBITDA 14.28
Cap/Depr 7093.99%
Cap/Sales 46.16%
Interest Coverage 2.47
Cash Conversion 96.61%
Profit Quality 15.27%
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z 0.79
F-Score5
WACC6.07%
ROIC/WACC0.39
Cap/Depr(3y)92.91%
Cap/Depr(5y)2757.51%
Cap/Sales(3y)0.79%
Cap/Sales(5y)21.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)293.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%555.14%
EPS Next Y-33.62%
EPS Next 2Y-17.65%
EPS Next 3Y-11.16%
EPS Next 5Y-8.21%
Revenue 1Y (TTM)7.21%
Revenue growth 3Y9.41%
Revenue growth 5Y7.46%
Sales Q2Q%5.94%
Revenue Next Year4.17%
Revenue Next 2Y4.84%
Revenue Next 3Y4.53%
Revenue Next 5Y4.44%
EBIT growth 1Y14.85%
EBIT growth 3Y12.55%
EBIT growth 5Y10.25%
EBIT Next Year31.96%
EBIT Next 3Y13.23%
EBIT Next 5YN/A
FCF growth 1Y-61.81%
FCF growth 3Y134.76%
FCF growth 5Y70.33%
OCF growth 1Y2.38%
OCF growth 3Y14.71%
OCF growth 5Y19.8%